Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii. (2020)
Attributed to:
DEALING WITH THERAPY-RESISTANT CRYPTOCOCCOSIS BY TARGETING INTRACELLULAR PATHOGENS
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/mmy/myz132
PubMed Identifier: 31915833
Publication URI: http://europepmc.org/abstract/MED/31915833
Type: Journal Article/Review
Volume: 58
Parent Publication: Medical mycology
Issue: 7
ISSN: 1369-3786